Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage

M. A. Repina; N. E. Lebedeva; L. P. Zdanuk; A. V. Ivanova

doi:10.17816/JOWD88936

Journal of obstetrics and women's diseases ›› 2000, Vol. 49 ›› Issue (1) :36 -38. DOI: 10.17816/JOWD88936

Original study articles

research-article

Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage

Author information +

History +

PDF

Abstract

The study was earned out to investigate effect of Progesterone 's agonist Dydrogesterone in the treatment оf the miscarriage. Thus, it was seen that Dydrogesterone 's treatment (10 mg/daily per os) zvas more effective than Progesterone for prophylactic miscarriage.

Keywords

didrogesterone / progesterone agonist / dufaston / threatened abortion

Cite this article

Download citation ▾

M. A. Repina, N. E. Lebedeva, L. P. Zdanuk, A. V. Ivanova. Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage. Journal of obstetrics and women's diseases, 2000, 49(1): 36-38 DOI:10.17816/JOWD88936

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Van Amsterdam P.Н., Overmars H., Scherpenisse P.M. Dydrogesterone: Metabolism in man. Eur. Drug. Metab. Pharmacokin, 1980, 5(3): 173-184.

[2]	Jager F.C., Michielsens P.M., et al. Summary of the properties of dydrogesterone. Solvay Report H., 1988, 102.053.

[3]	Crook D., Godland I. R, Stevenson J.C. The cardiovascularrisk profil of hormone replacement therapies containing dydrogesterone: a review. Eur. Menopause J., 1995; 2(4suppl.): 23-30.